Clinical trial · Interventional
Sonoguided-microwave Uterine Myoma
Efficacy Evaluation of Laparoscopic Sonoguided-microwave Uterine Myoma Ablation
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study mainly evaluates the resolution of uterine fibroids by microwave ablation. The medical equipment used is Ke Hui. "The Ampening ablation system is a percutaneous surgery. During laparoscopic surgery, it is directly ablated and soft, including problems that cannot be solved by partial or complete tissue ablation. "Hydrogen is used. If the expected range of ablation can be found, there is no need to wait for 3 to 6 months for ablation slowly like Haifu surgery. A fast, small, high-quality treatment that provides reference for medical treatment and helps doctors choose the most suitable treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Obstetric/Gynecology | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| "Covidien" Emprint Ablation System with Thermosphere Technology | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- therapy group
- interventionNames
- Device: "Covidien" Emprint Ablation System with Thermosphere Technology
Primary outcomes (2)
- measure
- Uterine myoma ablation
- timeFrame
- 1 momth
- description
- The ablation range of fibroids can be reduced by 50%, measured by MRI cubic centimeter volume.
- measure
- Improve bleeding
- timeFrame
- 3 momths
- description
- The hemoglobin changes before and 3 months after the operation are used to evaluate the improvement of patients' bleeding problems.
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: 1. Women who have reached the age of 20 and have not yet menopause. 2. Myoma size≧4cm. 3. Patients with submucosal fmyoma or intramural myoma of the uterus. Exclusion Criteria: 1. Patients with subserosal myoma. 2. Pregnant, breastfeeding or have menopause. 3. Pelvic infections, vaginitis, cervicitis or endometritis and have not been cured. 4. Malignant diseases of the cervix and uterus. 5. Abnormal reports of clinical significance in Pap smear or thin-layer cell test. 6. Abnormal blood coagulation function or liver and kidney function, with bleeding tendency. 7. There is no safe puncture treatment route. 8. Those who have installed intrauterine contraceptive device or Pacemaker. 9. Those who cannot perform vaginal ultrasound, such as those who have no sexual experience and do not accept hymen repair.
References
Publications (0)
Data not yet available